India Glycols Limited (IN:INDIAGLYCO)
:INDIAGLYCO
Top Page
India Glycols Limited
(INDIAGLYCO)
Select Model
Select Model
Rating:65Neutral
Price Target:
₹968.00
▼(-3.93% Downside)
Action:ReiteratedDate:11/18/25
India Glycols Limited's stock score is driven by strong technical momentum, despite financial challenges such as declining margins and high leverage. The valuation suggests potential overvaluation, and the low dividend yield limits income appeal. The absence of earnings call and corporate events data means these factors do not influence the score.
Positive Factors
Specialty and renewable feedstock product mix
A diversified product portfolio spanning glycols, glycol ethers and downstream specialties tied to renewable agro feedstock supports durable demand across pharma, personal care and industrial end-markets. Value-added derivatives and renewables exposure help sustain margins and reduce commodity cyclicality over months.
Negative Factors
Rising leverage
An increased debt-to-equity ratio of 0.84 materially raises financial risk and interest obligations. Over a multi-month horizon higher leverage constrains strategic flexibility, limits capacity for opportunistic investments or buybacks, and amplifies vulnerability to demand shocks or margin pressure.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialty and renewable feedstock product mix
A diversified product portfolio spanning glycols, glycol ethers and downstream specialties tied to renewable agro feedstock supports durable demand across pharma, personal care and industrial end-markets. Value-added derivatives and renewables exposure help sustain margins and reduce commodity cyclicality over months.
Read all positive factors
India Glycols Limited (INDIAGLYCO) vs. iShares MSCI India ETF (INDA)
Market Cap
₹61.43B
Dividend Yield0.47%
Average Volume (3M)19.23K
Price to Earnings (P/E)23.5
Beta (1Y)1.65
Revenue Growth5.61%
EPS Growth33.63%
CountryIN
Employees1,326
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)10.05
Shares Outstanding67,026,764
10 Day Avg. Volume24,007
30 Day Avg. Volume19,229
Financial Highlights & Ratios
PEG Ratio0.23
Price to Book (P/B)0.79
Price to Sales (P/S)0.47
P/FCF Ratio-4.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)63.63
Revenue Forecast (FY)₹47.50B
India Glycols Limited Business Overview & Revenue Model
Company Description
India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. The company operates through Industrial Chemical, Ethyl Alcohol, and Nutraceuticals segments. It offers monoethylene, diethylene, and triet...
How the Company Makes Money
India Glycols makes money mainly by manufacturing and selling chemical products to industrial customers. Its revenue model is product-sales driven and typically includes: (1) Sale of bulk and specialty chemicals: The company generates revenue from...
India Glycols Limited Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
58
Neutral
Cash Flow
52
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.71B | 37.68B | 32.94B | 26.37B | 28.68B | 22.92B |
| Gross Profit | 13.76B | 9.99B | 10.55B | 10.69B | 8.45B | 7.06B |
| EBITDA | 6.26B | 5.11B | 4.28B | 3.47B | 4.98B | 2.86B |
| Net Income | 2.59B | 2.31B | 1.73B | 1.25B | 3.40B | 1.32B |
Balance Sheet | ||||||
| Total Assets | 61.57B | 61.76B | 56.17B | 48.58B | 46.31B | 41.19B |
| Cash, Cash Equivalents and Short-Term Investments | 1.53B | 546.92M | 746.42M | 2.83B | 430.66M | 396.11M |
| Total Debt | 20.55B | 18.92B | 13.48B | 11.12B | 10.42B | 11.37B |
| Total Liabilities | 37.64B | 39.20B | 35.66B | 29.57B | 28.58B | 29.51B |
| Stockholders Equity | 23.94B | 22.56B | 20.51B | 19.01B | 17.92B | 11.69B |
Cash Flow | ||||||
| Free Cash Flow | -650.60M | -3.98B | -1.14B | -1.13B | -2.64B | -115.54M |
| Operating Cash Flow | 1.06B | 3.62B | 4.39B | 3.26B | 1.16B | 1.37B |
| Investing Cash Flow | -1.59B | -7.36B | -5.03B | -3.30B | 764.47M | -1.48B |
| Financing Cash Flow | 637.20M | 3.54B | 899.12M | -5.10M | -1.89B | 107.45M |
India Glycols Limited Technical Analysis
Positive
1007.65
Price Trends
886.19
Positive
957.22
Negative
931.30
Negative
Market Momentum
1.51
Negative
57.36
Neutral
89.21
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDIAGLYCO, the sentiment is Positive. The current price of 1007.65 is above the 20-day moving average (MA) of 867.80, above the 50-day MA of 886.19, and above the 200-day MA of 931.30, indicating a neutral trend. The MACD of 1.51 indicates Negative momentum. The RSI at 57.36 is Neutral, neither overbought nor oversold. The STOCH value of 89.21 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:INDIAGLYCO.
India Glycols Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹61.66B | 12.10 | ― | 3.68% | -7.53% | 42.74% | |
65 Neutral | ₹43.13B | -46.40 | ― | 3.11% | 10.35% | ― | |
65 Neutral | ₹61.43B | 23.54 | ― | 0.47% | 5.61% | 33.63% | |
62 Neutral | ₹43.17B | 20.39 | ― | 0.28% | 6.44% | 36.54% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ₹34.73B | 46.14 | ― | 0.29% | -2.93% | -37.94% | |
44 Neutral | ₹21.04B | -19.42 | ― | ― | 9.21% | 87.89% |
* Basic Materials Sector Average
IN:INDIAGLYCO
India Glycols Limited
901.20
299.26
49.72%
IN:CAMLINFINE
Camlin Fine Sciences Limited
104.03
-56.22
-35.08%
IN:GNFC
Gujarat Narmada Valley Fertilizers & Chemicals Ltd.
428.70
-35.71
-7.69%
IN:GUJALKALI
Gujarat Alkalies & Chemicals Ltd.
617.25
30.76
5.24%
IN:LXCHEM
Laxmi Organic Industries Ltd.
124.20
-46.22
-27.12%
IN:SUNFLAG
Sunflag Iron & Steel Co. Ltd.
238.30
6.46
2.79%
India Glycols Limited Corporate Events
India Glycols shareholders clear NCLT-driven scheme of arrangement
Mar 24, 2026
India Glycols Limited held a court-convened meeting of its equity shareholders on 24 March 2026 via video conference, as directed by the National Company Law Tribunal, Allahabad Bench. The meeting was properly constituted with appointed chairperso...
India Glycols’ Unsecured Creditors Clear Scheme Resolution Under NCLT Supervision
Mar 24, 2026
India Glycols Limited reported the outcome of a court-convened meeting of its unsecured creditors held via video conference on 24 March 2026, as directed by the National Company Law Tribunal, Allahabad Bench. The meeting, attended by 27 unsecured ...
India Glycols Gets Major Relief as Customs Appeal Cuts Penalties, Plans Second Challenge
Mar 13, 2026
India Glycols Limited has disclosed that the Commissioner (Appeals), Noida has partially upheld an earlier customs order confirming a demand of Rs. 33.43 crore as short‑paid duty, along with applicable interest and a reduced penalty of Rs. 4...
India Glycols to Weigh Interim Dividend, Closes Trading Window
Mar 10, 2026
India Glycols Limited has scheduled a board meeting on 17 March 2026 to consider the declaration of an interim dividend for the 2025-26 financial year, signaling a potential payout to shareholders depending on the board’s decision. In line w...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.